Response from NICE to Andy Reed's concerns about the availability of the drug abatacept (Orencia) for refractory rheumatoid arthritis.

Andy has written to the National Institute for Health and Clinical Excellence, raising concerns about the access to rheumatoid arthritis drugs. the response, see below, encourages people who are seeking the drug to ask for it from doctors as the letter makes clear that it possible for it to be prescribed at present.